{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:58:39Z","timestamp":1789437519426,"version":"build-2803163510"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0107594","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T17:52:48Z","timestamp":1411149168000},"page":"e107594","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Novel Mutations in FKBP10 and PLOD2 Cause Rare Bruck Syndrome in Chinese Patients"],"prefix":"10.1371","volume":"9","author":[{"given":"Peiran","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.31334","article-title":"Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings","volume":"160C","author":"M Rohrbach","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-genet-110711-155608","article-title":"Recessively inherited forms of osteogenesis imperfecta","volume":"46","author":"PH Byers","year":"2012","journal-title":"Annu Rev Genet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.1989.tb03174.x","article-title":"Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome)","volume":"36","author":"D Viljoen","year":"1989","journal-title":"Clin Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/ajmg.a.35938","article-title":"Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations","volume":"161","author":"JA Caparr\u00f3s-Martin","year":"2013","journal-title":"Am J Med Genet A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ajmg.a.30231","article-title":"Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2","volume":"131","author":"R Ha-Vinh","year":"2004","journal-title":"Am J Med Genet A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ajhg.2010.02.022","article-title":"Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta","volume":"86","author":"Y Alanay","year":"2010","journal-title":"Am J Hum Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1002\/humu.22133","article-title":"Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome\u2014osteogenesis imperfecta phenotypic spectrum","volume":"33","author":"MT Puig-Herv\u00e1s","year":"2012","journal-title":"Hum Mutat"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New genes in bone development: what&apos;s new in osteogenesis imperfecta","volume":"98","author":"JC Marini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ajhg.2010.05.020","article-title":"FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?","volume":"87","author":"R Shaheen","year":"2010","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1073\/pnas.96.3.1054","article-title":"Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17","volume":"96","author":"RA Bank","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1179\/146532809X440798","article-title":"Bruck syndrome: osteogenesis imperfecta and arthrogryposis multiplex congenital","volume":"29","author":"H Yapicio\u011flu","year":"2009","journal-title":"Ann Trop Paediatr"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/jbmr.5650091002","article-title":"Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results","volume":"9","author":"HK Genant","year":"1994","journal-title":"J Bone Miner Res"},{"key":"ref13","first-page":"134","article-title":"Normal reference values for bone mineral density in children and adolescents aged 6\u201318 years, Beijing, China","volume":"9","author":"LW Zhang","year":"2003","journal-title":"Chin J Osteoporosis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.1989.tb03174.x","article-title":"Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome)","volume":"36","author":"D Viljoen","year":"1989","journal-title":"Clin Genet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/dds371","article-title":"Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen","volume":"22","author":"U Schwarze","year":"2013","journal-title":"Hum Mol Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ajmg.a.34025","article-title":"Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans","volume":"155A","author":"R Shaheen","year":"2011","journal-title":"Am J Med Genet A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s000180050299","article-title":"Peptidyl-prolylcis-trans isomerases, a superfamily of ubiquitous folding catalysts","volume":"55","author":"SF G\u00f6thel","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12192-011-0270-x","article-title":"Endoplasmic reticulum stress or mutation of an EF-hand Ca<sup>2+<\/sup>-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysis","volume":"16","author":"LA Murphy","year":"2011","journal-title":"Cell Stress Chaperones"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/humu.22139","article-title":"Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix","volume":"33","author":"AM Barnes","year":"2012","journal-title":"Hum Mutat"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"31584","DOI":"10.1074\/jbc.M802535200","article-title":"The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens","volume":"283","author":"Y Ishikawa","year":"2008","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/humu.22362","article-title":"Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations","volume":"34","author":"AM Barnes","year":"2013","journal-title":"Hum Mutat"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2010.01.034","article-title":"Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta","volume":"86","author":"HE Christiansen","year":"2010","journal-title":"Am J Hum Genet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/jbmr.250","article-title":"Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome","volume":"26","author":"BP Kelley","year":"2011","journal-title":"J Bone Miner Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bone.2011.10.023","article-title":"A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect","volume":"50","author":"G Venturi","year":"2012","journal-title":"Bone"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"40967","DOI":"10.1074\/jbc.M307380200","article-title":"Identification of <italic>PLOD2<\/italic> as telopeptide lysyl hydroxylase, an important enzyme in fibrosis","volume":"278","author":"AJ van der Slot","year":"2003","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejmg.2011.10.002","article-title":"A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient","volume":"55","author":"ED Setijowati","year":"2012","journal-title":"Eur J Med Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1179\/146532809X440798","article-title":"Bruck syndrome: osteogenesis imperfecta and arthrogryposis multiplex congenita","volume":"29","author":"H Yapicio\u011flu","year":"2009","journal-title":"Ann Trop Paediatr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00776-005-0958-9","article-title":"Bruck syndrome: congenital joint contractures with bone fragility","volume":"10","author":"L Mokete","year":"2005","journal-title":"J Orthop Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-8628(19970502)70:1<28::AID-AJMG6>3.0.CO;2-N","article-title":"Bruck syndrome (osteogenesis imperfecta with congenital joint contractures): review and report on the first North American case","volume":"70","author":"E McPherson","year":"1997","journal-title":"Am J Med Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2010.88","article-title":"Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates","volume":"12","author":"JM Olmos","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.5650090706","article-title":"Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta","volume":"9","author":"RE Brenner","year":"1994","journal-title":"J Bone Miner Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1442-200X.2008.02752.x","article-title":"Cyclic pamidronate treatment in Bruck syndrome: proposal of a new modality of treatment","volume":"50","author":"N Andiran","year":"2008","journal-title":"Pediatr Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"N Bishop","year":"2013","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2012-0016","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"ER Barros","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref35","first-page":"245","article-title":"Effects of zoledronic acid in adults with osteogenesis imperfecta","volume":"57","author":"I Pav\u00f3n de Paz","year":"2010","journal-title":"Endocrinol Nutr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BPO.0b013e3182a006a0","article-title":"Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy","volume":"34","author":"T Sousa","year":"2014","journal-title":"J Pediatr Orthop"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0107594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T05:53:53Z","timestamp":1565848433000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0107594"}},"subtitle":[],"editor":[{"given":"Andreas R.","family":"Janecke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0107594","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]}}}